The success of this therapeutic regimen was associated with significant immune modulation, including a reduction in Treg, an increase in natural killer cells, maturation of lymphocytes to the effector memory stage, and production of IFN-γ and IL-4 by circulating T cells in response to tumor-specific antigen encoded peptides [175]. Here, IFNG is linked to neoplasm.